Summary
Drugs preferentially influencing dopaminergic neurotransmission mechanisms were administered to rats which lever-pressed to receive electrical stimulation in either the lateral hypothalamus or periaqueductal mesencephalon. The same drug effects were observed regardless of the site of electrical stimulation. Blockade of dopamine receptors by 0.35 or 0.5 mg/kg pimozide reduced self-stimulation rates. Increasing the reward value of the stimulation by doubling of self-stimulation current induced control rates of lever-pressing in animals given 0.35 mg/kg pimozide but not in those receiving 0.5 mg/kg. At doses of 0.75 and 1.5 mg/kg, apomorphine, a putative dopamine receptor stimulator, reduced self-stimulation rates at normal current. Doubling of the stimulation current produced greater than normal rates of lever-pressing at 0.75 mg/kg apomorphine, but at 1.5 mg/kg no such increase in rate was observed. l-DOPA, 75 and 150 mg/kg, also reduced self-stimulation, but doubled current restored rates to control levels at both doses. For comparison purposes, pharmacological effects on predominantly noradrenergic mechanisms were also studied. Inhibition of dopamine-β-hydroxylase by 150 mg/kg disulfiram reduced self-stimulation under normal current, but rates were increased to above control levels with doubled current. That self-stimulation behavior could be reinstated by doubling of current suggests that motor incapacity is not a sufficient explanation for most of the observed reductions in lever-pressing rate. These results further suggest that, in addition to noradrenaline, the integrity of central dopaminergic systems may be essential for the behavioral expression of certain motivational processes.
Similar content being viewed by others
References
Andén, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K., Ungerstedt, U.: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Europ. J. Pharmacol. 11, 303–314 (1970).
Andén, N.-E., Rubenson, A., Fuxe, K., Hokfelt, T.: Evidence for dopamine receptor stimulation by apomorphine. J. Pharm. Pharmacol. 19, 627–632 (1967).
Angrist, B., Gershon, S.: A pilot study of pathogenic mechanisms in amphetamine psychosis utilizing differential effects of D and L amphetamine. Pharmakopsychiat. Neuro-Psychopharmak. 4, 64–75 (1971).
Breese, G. R., Howard, J. L., Leahy, J. P.: Effect of 6-hydroxydopamine on electrical self-stimulation of the brain. Brit. J. Pharmacol. 43, 255–257 (1971).
Brugmans, J.: A multicentric clinical evaluation of pimozide. Preliminary report. Acta neurol. belg. 68, 875–887 (1968).
Butcher, L. L.: Effects of apomorphine on free-operant avoidance behavior in the rat. Europ. J. Pharmacol. 3, 163–166 (1968).
Butcher, L. L., Andén, N.-E.: Effects of apomorphine and amphetamine on schedule-controlled behavior: reversal of tetrabenazine suppression and dopaminergic correlates. Europ. J. Pharmacol. 6, 255–264 (1969).
Butcher, L. L., Engel, J.: Behavioral and biochemical effects of l-Dopa after peripheral decarboxylase inhibition. Brain Res. 15, 233–242 (1969).
Butcher, L. L., Engel, J., Fuxe, K.: Behavioral, biochemical and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition. Brain Res. 41, 387–411 (1972).
Carlsson, A.: Functional significance of drug-induced changes in brain monoamine levels. Progr. Brain Res. 8, 9–27 (1964).
Cooper, B. R., Black, W. C., Paolino, R. M.: Decreased septal-forebrain and lateral hypothalamic reward after alpha methyl-p-tyrosine. Physiol. Behav. 6, 425–430 (1971).
Crow, T. J.: Enhancement by cocaine of intracranial self-stimulation in the rat. Life Sci. 9, (Part I), 375–381 (1970).
Fog, R. L.: Stereotyped and non-stereotyped behaviour in rats induced by various stimulant drugs. Psychopharmacologia (Berl.) 14, 299–304 (1969).
Gibson, S., McGeer, E. G., McGeer, P. L.: Effect of selective inhibitors of tyrosine and tryptophan hydroxylases on self-stimulation in the rat. Exp. Neurol. 27, 283–290 (1970).
Goldstein, M., Nakajima, K.: The effect of disulfiram on catecholamine levels in the brain. J. Pharmacol. exp. Ther. 157, 96–102 (1967).
Hodos, W., Valenstein, E. S.: An evaluation of response rate as a measure of rewarding intracranial stimulation. J. comp. physiol. Psychol. 55, 80–84 (1962).
Janssen, P. A. J., Niemegeers, C. J. E., Schellebens, K. H. L., Dresse, A., Lenaerts, F. M., Pinchard, A., Schaper, W. K. A., Van Nueten, J. M., Verbruggen, F. J.: Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine. Arzeimittel-Forsch. 18, 261–279 (1968).
Margules, D. L.: Noradrenergic rather than serotonergic basis of reward in the dorsal tegmentum. J. comp. physiol. Psychol. 67, 32–35 (1969).
Moore, K. E.: Effects of disulfiram and diethyldithiocarbamate on spontaneous locomotor activity and brain catecholamine levels in mice. Biochem. Pharmacol. 18, 1627–1634 (1969).
Munkvad, I., Pakkenberg, H., Randrup, A.: Aminergic systems in basal ganglia associated with stereotyped hyperactive behavior and catalepsy. Brain Behav. Evol. 1, 89–100 (1968).
Olds, M. E.: Comparative effects of amphetamine, scopolamine, chlordiazepoxide and diphenylhydantoin on operant and extinction behavior with brain stimulation and food reward. Neuropharmacology 9, 519–532 (1970).
Pellegrino, L. J., Cushman, A. J.: A stereotaxic atlas of the rat brain. New York: Appleton-Century-Crofts 1967.
Poschel, B. P. H., Ninteman, F. W.: Excitatory (anti-depressant?) effects of monoamine oxidase inhibitors on the reward system of the brain. Life Sci. 3, 903–910 (1964).
Randrup, A., Munkvad, I., Udsen, P.: Adrenergic mechanisms and amphetamine-induced abnormal behavior. Acta pharmacol. (Kbh.) 20, 145–157 (1963).
Rech, R., Borys, H., Moore, K.: Alterations in behavior and brain catecholamine levels in rats treated with α-methyl-tyrosine. J. Pharmacol. exp. Ther. 153, 412–419 (1966).
Reynolds, R. W.: The relationship between stimulation voltage and rate of hypothalamic self-stimulation in the rat. J. comp. physiol. Psychol. 51, 193–198 (1958).
Roll, S. K.: Intracranial self-stimulation and wakefulness: Effect of manipulating ambient brain catecholamines. Science 168, 1370–1372 (1970).
Stein, L.: Self-stimulation of the brain and the central stimulant action of amphetamine. Fed. Proc. 23, 836–850 (1964).
Stein, L.: Chemistry of purposive behavior. In: Reinforcement and Behavior. pp. 328–355. J. T. Tapp, ed. New York: Academic Press 1969.
Stein, L., Wise, C. D.: Release of norepinephrine from hypothalamus and amygdala by rewarding medial forebrain bundle stimulation and amphetamine. J. comp. physiol. Psychol. 67, 189–198 (1969).
Stein, L., Wise, C. D.: Possible etiology of schizophrenia: Progressive damage to the noradrenergic reward system by 6-hydroxydopamine. Science 171, 1032–1036 (1971).
Ungerstedt, U.: Adipsia and aphagia after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine system. Acta physiol. scand. Suppl. 367, 95–122 (1971a).
Ungerstedt, U.: Stereotaxic mapping of the monoamine pathways in the rat brain. Acta physiol. scand., Suppl. 367, 1–48 (1971b).
Uretsky, J., Iversen, L. L.: Effects of 6-hydroxydopamine on catecholamine containing neurons in the rat brain. J. Neurochem. 17, 269–278 (1970).
Winer, B. J.: Statistical principles in experimental design. New York: McGraw-Hill 1962.
Wise, C. D., Stein, L.: Facilitation of brain self-stimulation by central administration of norepinephrine. Science 163, 299–301 (1969).
Wolfle, T. L., Mayer, D. J., Carder, B., Liebeskind, J. C.: Motivational effects of electrical stimulation in dorsal tegmentum of the rat. Physiol. Behav. 7, 569–574 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liebman, J.M., Butcher, L.L. Effects on self-stimulation behavior of drugs influencing dopaminergic neurotransmission mechanisms. Naunyn-Schmiedeberg's Arch. Pharmacol. 277, 305–318 (1973). https://doi.org/10.1007/BF00505669
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00505669